Lakhvir Kaur
Overview
Explore the profile of Lakhvir Kaur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Zarkali O, Marker A, Kaur L, VanDerWall A
Cureus
. 2024 Apr;
16(3):e55414.
PMID: 38567210
This case describes a unique presentation of a rare malignancy: giant melanoma. Due to the accessibility of healthcare in the United States, it is unusual for melanomas to grow to...
2.
Singh L, Kaur L, Singh G, Dhawan R, Kaur M, Kaur N, et al.
AAPS PharmSciTech
. 2022 Jul;
23(6):209.
PMID: 35902454
The present study is focused on the use of solid dispersion technology to triumph over the solubility-related problems of bexarotene which is currently used for treating various types of cancer...
3.
Mahajan A, Kaur L, Singh G, Dhawan R, Singh L
Recent Adv Antiinfect Drug Discov
. 2021 Nov;
16(3):182-195.
PMID: 34766898
Luliconazole is a broad-spectrum antifungal agent with impactful fungicidal and fungistatic activity. It has shown exceptional potency against miscellaneous fungal strains like Candida, Aspergillus, Malassezia, Fusarium species and various dermatophytes....
4.
Kaur A, Kaur L, Singh G, Dhawan R, Mahajan A
Recent Pat Nanotechnol
. 2021 Apr;
16(4):295-307.
PMID: 33913409
Nanotechnology in association with herbal medicine can lead to enhanced therapeutic and diminished adverse effects of medication. In turn, it can lead to synergistic effects of administered compound overcoming its...
5.
Singh M, Kaur L, Bajaj R, Arodhia S
Adv Respir Med
. 2021 Feb;
89(2):203-206.
PMID: 33559119
Carbapenemase-producing Klebsiella pneumoniae is an emerging threat worldwide. The appropriate therapy for infections due to these multidrug-resistant pathogens is not well defined and depends upon the susceptibilities of individual isolates,...
6.
Singh A, Mukhtar H, Kaur H, Kaur L
Nat Prod Res
. 2019 Jan;
34(17):2514-2517.
PMID: 30600705
This study emphasizes on the investigation of antiplasmodial activity of triterpenoids isolated from leaves. An unsaponified fraction of petroleum ether extract of plant leaves was subjected to silica gel column...
7.
Kaur L, Singh K, Paul S, Singh S, Singh S, Jain S
AAPS PharmSciTech
. 2018 Mar;
19(4):1606-1624.
PMID: 29488196
Type of biological membrane used in skin permeation experiment significantly affects skin permeation and deposition potential of tested formulations. In this study, a comparative study has been carried out to...
8.
Kaur L, Abhijeet , Jain S
Recent Pat Nanotechnol
. 2017 Jan;
11(3):214-234.
PMID: 28056751
Background: Amphotericin B, designated as the gold standard among antifungal drugs is the only fungicidal effective against systemic fungal infections. But this drug has various pitfalls associated with it, to...
9.
Kaur L, Jain S, Manhas R, Sharma D
J Liposome Res
. 2014 Dec;
25(4):294-307.
PMID: 25547800
The present study is envisaged to develop nanoethosomal formulation for enhanced topical delivery of amphotericin B (AmB) for the treatment of cutaneous fungal infections. AmB encapsulated nanoethosomes were prepared using...